
Markolines Pavement Technologies Limited Receives Listing and Trading Approval on NSE and BSE
Markolines Pavement Technologies Limited has received official listing and trading approval from both the National Stock Exchange of India Limited (NSE) and BSE Limited. The company is authorized to list and trade 1,62,800 Equity Shares with a face value of Rs. 10 each on the Main Board of both exchanges.The listing and trading of these shares will commence on Monday, July 20, 2026. The company stated that this development serves as a significant milestone intended to enhance its market presence, strengthen investor outreach, and support long-term value creation.
Listing Details and Share Allotment
The approved listing includes equity shares allotted pursuant to the conversion of warrants issued through preferential issues. The total number of securities admitted to dealings is 1,62,800.The specific breakdown of the security descriptions and distinctive numbers is as follows:
| Sr. No. | Security Description | Symbol | Series | No. of Securities | Distinctive Numbers |
|---|---|---|---|---|---|
| 1. | Equity shares allotted pursuant to conversion of warrants (Preferential Issue) | MARKOLINES | EQ | 22,800 | 22040921 to 22063720 |
| 2. | Equity shares allotted pursuant to conversion of warrants (Preferential Basis) | MARKOLINES | EQ | 1,40,000 | 22063721 to 22203720 |
Lock-in Period Specifications
The equity shares issued to non-promoters on a preferential basis are subject to specific lock-in periods. The details regarding the number of shares and their respective distinctive numbers for the lock-in period until January 20, 2027, are detailed below:| No. of Shares | Distinctive Numbers From | Distinctive Numbers To | Lock-in Date |
|---|---|---|---|
| 40,000 | 22063721 | 22103720 | 20-Jan-2027 |
| 100,000 | 22103721 | 22203720 | 20-Jan-2027 |
| 140,000 | Total | Total | 20-Jan-2027 |
| Total | Total | Total | 20-Jan-2027 |
The transaction involves the issuance of these shares at a premium of Rs. 155 per share. The company confirmed that the listing and trading approvals were received via formal correspondence from both exchanges on July 17, 2026.
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.